Association between serum irisin levels and non- Alcoholic fatty liver disease in health screen examinees

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Choi, Eun Sung ^a   Kim, Mi Kyung ^a   Song, Min Kyung ^b   Kim, Jeong Min ^a   Kim, Eun Soo ^a   Chung, Woo Jin ^a   Park, Kyung Sik ^a   Cho, Kwang Bum ^a   Hwang, Jae Seok ^a   Jang, Byoung Kuk ^a,b  

^a Keimyung University School of Medicine   (South Korea)

^b Keimyung University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CHOLESTEROL; CYTOKINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; IRISIN; LEPTIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ABDOMINAL RADIOGRAPHY; ADULT; ALCOHOLIC FATTY LIVER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MALE; MASS SCREENING; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; BLOOD; CASE CONTROL STUDY; COMPLICATION; EXERCISE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OBESITY;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; FIBRONECTINS; HUMANS; MALE; MASS SCREENING; METABOLIC SYNDROME X; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

EID: 84908501880     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110680     Document Type: Article

References (17)

1. Angulo P (2002) Nonalcoholic fatty liver disease. The New England journal of medicine 346: 1221-1231.
2. Sahini N, Borlak J (2014) Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes. Progress in lipid research 54: 86-112.
3. Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, et al. (2012) FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61: 1725-1738.
4. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, et al. (2012) A PGC1- alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481: 463-468.
5. Moon HS, Dincer F, Mantzoros CS (2013) Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines. Metabolism: clinical and experimental 62: 1131-1136.
6. Polyzos SA, Kountouras J, Shields K, Mantzoros CS (2013) Irisin: a renaissance in metabolism? Metabolism: clinical and experimental 62: 1037-1044.
7. Polyzos SA, Kountouras J, Anastasilakis AD, Geladari EV, Mantzoros CS (2014)Irisin in patients with nonalcoholic fatty liver disease. Metabolism: clinical and experimental 63: 207-217.
8. Chang Y, Jung HS, Yun KE, Cho J, Cho YK, et al. (2013) Cohort study of nonalcoholic fatty liver disease, NAFLD fibrosis score, and the risk of incident diabetes in a Korean population. The American journal of gastroenterology 108: 1861-1868.
9. Kassi E, Pervanidou P, Kaltsas G, Chrousos G (2011) Metabolic syndrome: definitions and controversies. BMC medicine 9: 48.
10. Zhang HJ, Zhang XF, Ma ZM, Pan LL, Chen Z, et al. (2013) Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. Journal of hepatology 59: 557-562.
11. Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, et al. (2013) Lower circulating irisin is associated with type 2 diabetes mellitus. Journal of diabetes and its complications 27: 365-369.
12. Hee Park K, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-Efe A, et al. (2013)Circulating irisin in relation to insulin resistance and the metabolic syndrome. The Journal of clinical endocrinology and metabolism 98: 4899-4907.
13. Bostrom PA, Fernandez-Real JM, Mantzoros C (2014) Irisin in humans: recent advances and questions for future research. Metabolism: clinical and experimental 63: 178-180.
14. Sanchis-Gomar F, Alis R, Pareja-Galeano H, Sola E, Victor VM, et al. (2014)Circulating irisin levels are not correlated with BMI, age, and other biological parameters in obese and diabetic patients. Endocrine 2014 Feb 8.
15. Kraemer RR, Shockett P, Webb ND, Shah U, Castracane VD (2014) A transient elevated irisin blood concentration in response to prolonged, moderateaerobic exercise in young men and women. Hormone and metabolic research 46: 150-154.
16. Sanchis-Gomar F, Alis R, Pareja-Galeano H, Romagnoli M, Perez-Quilis C (2014) Inconsistency in Circulating Irisin Levels: What is Really Happening? Hormone and metabolic research 2014 Jan 23.
17. Raschke S, Elsen M, Gassenhuber H, Sommerfeld M, Schwahn U, et al. (2013)Evidence against a beneficial effect of irisin in humans. PloS one 8:e73680.